The ABPI MD device allows consistent and reliable ABI measurements to be taken without requiring any special training. The 2-minute test can be performed by a practice Doctor or Nurse very easily. Screening for Peripheral Artery Disease in general practice is now practical and affordable.
Diagnosis of PAD in only
We have designed and developed the first valuable automated ankle-brachial index measuring device (ABPI MD), based on oscillometric method (one of the plethysmographic techniques). The blood pressure on the upper and lower extremities is measured simultaneously, resulting in the calculation of the ankle-brachial index (ABI). The result of the examination is clear and straight forward. Only what is really important – the left ABI, right ABI and brachial blood pressure – are displayed. The measurement is repeatable and can be performed in only three minutes, instead of the usual 30 minutes that are required by the Doppler ultrasound method.
2 in 1: ABI and BP measurement
This is not just a medical device for ABI; this is a medical device for the simple, objective and accurate measurement of ABI and blood pressure. The expertly developed ABPI MD has two measurement modes:
Stand-alone measurement of brachial blood pressure and heart rate.
Simultaneous measurement of the left ABI, the right ABI, blood pressure and heart rate.
Therefore, ABPI MD can be used for measuring brachial blood pressure on all patients visiting the general practitioner. It is also used as a screening tool for patients with non-modifiable and modifiable risk factors for the occurrence of cardiovascular diseases.
Colour coded cuffs simplify the use of the device. The different colours indicate where to place each cuff. The red cuff should be positioned on the upper arm, green on the right and yellow on the left ankle. Each cuff is clearly labelled and includes a diagram to ensure correct placement, so no training is needed as comprehensive guidelines are provided.
Hemolung®RAS first ECCO2R System Approved and Commercially Available in Australia!
Hemolung®RAS the first ECCO2R System to be approved and commercially available in Australia! Getz Healthcare and ALung Technologies, Inc. are pleased to announce that the Hemolung® Respiratory Assist system for delivering the ECCO2R therapy has now gained TGA registration, allowing promotion and placement to Level 3 ICUs throughout Australia.
Getz Healthcare Gives Back for Christmas
Here at Getz Healthcare we are keenly aware of how difficult it can be for some families during the Christmas period. In an effort to make the joyous season a little easier for struggling families, each year Getz Healthcare takes part in The Salvation Army’s Hope Christmas Appeal.
1300 - 668 - 140
5 Orion Road,
Lane Cove NSW 2066